Press Releases

Page Category: 

International Revenue increases 81%TITAN Sales Exceed 60% of Worldwide RevenueJapan Distribution Agreement Signed for iLook 25 BOTHELL, WA, July 29, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced significantly improved results for the second quarter ended June 30, 2004 as compared with the second quarter of 2003. Worldwide revenue in the second quarter of 2004 grew 30% to $26.1 million compared with $20.1 million in the second quarter of 2003. For the first half of 2004, the Company's total revenue grew 33% to $49.6 million compared with $37.3 million for the first half of the prior year. Year-over-year, changes in foreign currency rates increased the revenue growth rate by two percentage points for the second quarter and three percentage points for the first half. For the second quarter of 2004, Sonosite reported a net loss of $64,000, or approximately breakeven on a per...

SEATTLE, WA, July 29, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high-performance, hand-carried ultrasound, and Nippon Sherwood Medical Industries Ltd., Japan's leading manufacturer of central venous catheters (CVCs), announced today that they have signed a two-year distribution agreement for the Japanese vascular access market. Under the terms of the agreement, Nippon Sherwood will become the exclusive distributor of Sonosite's iLook' 25 system for the vascular access market in Japan. Weighing only 3 pounds (1.4kg.), the all-digital iLook 25 system is specifically designed to provide fast, accurate guidance for vascular access. The alliance will leverage Nippon Sherwood's strong distribution channels to deliver the iLook25 system to catheterization labs, surgical suites, critical care units and other point-of-care locations where catheters and lines for vascular access are placed. "We are excited about the growing opportunity for the Sonosite iLook 25 product in Japan," said Seiji Kato, general manager of Sales and Marketing of Nippon Sherwood. "The use of ultrasound guidance for vascular line placement has been shown to improve patient safety and comfort associated with these interventional procedures and is becoming standard medical practice in the United States and United Kingdom. We look forward to working with Sonosite to pioneer this market in Japan and establishing the iLook 25 system as the new standard of care for CVC procedures in this country."

Conference Call Accessible Via Live WebcastBOTHELL, WA, July 16, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high-performance, hand-carried ultrasound, today announced that the Company will report its second quarter financial results on Thursday, July 29, 2004 at the close of market and hold a conference call at 1:30 pm PDT/4:30 pm EDT to discuss its second quarter performance, outlook for 2004 and current corporate developments. The call will be broadcast live and can be accessed via the "Investors" Section of Sonosite's website at www.sonosite.com. A replay of the audio webcast will be available beginning July 29, 2004, 4:30 pm (PDT) until August 13, 2004, 12:00 midnight (PDT) by dialing (719) 457 0820 or toll-free (888) 203 1112. The confirmation code (589270) is required to access the replay. The call will be also archived on Sonosite's website at http://ir.sonosite.com/. About Sonosite

BOTHELL, WA, June 30, 2004 - Sonosite, Inc. (Nasdaq: SONO), the worldwide leader in high-performance, hand-carried ultrasound, announced today that it has signed a distribution agreement for Japan with Aloka Co., Ltd., a leading Japanese manufacturer and distributor of ultrasound systems. The agreement names Aloka as Sonosite's exclusive distributor for TITAN, the Company's newest generation of high performance, hand-carried ultrasound systems, for all of Japan's clinical ultrasound markets, including cardiology, abdominal, vascular, Ob/gyn and emergency medicine. "This agreement brings together two leaders in ultrasound," said Mr. Yoshihiro Yoshikawa, President, Aloka Co. Ltd. "Hand-carried ultrasound is Japan's most rapidly growing ultrasound market. Aloka is fully committed to optimizing this major opportunity through this strategic alliance with Sonosite and to bringing the finest hand-carried ultrasound available to Japan's medical practitioners."

Upgrade Provides Complete Capabilities for Echo Studies;Addresses $460 Million International Shared Services Market BOTHELL, WA, June 23, 2004 - Sonosite, Inc. (Nasdaq: SONO), the worldwide leader in high-performance, hand-carried ultrasound, said today that it has begun customer shipments of cardiology/shared service capabilities for the TITAN system, the Company's most advanced, high resolution, hand-carried system.

"This upgrade represents our fourth major expansion of the TITAN system's capabilities since its introduction a little over a year ago," said Kevin M. Goodwin, Sonosite President and CEO. "This latest release enables physicians to perform full echocardiography and vascular studies in the clinic or at the point-of-care, allowing for earlier diagnosis and treatment. It also addresses the need of many of our international customers who require a shared service system that can perform both radiology and cardiology examinations. The shared service market is estimated to account for at least 20% of the $2.3 billion...

Acquisition of SonoMetric Health Signals Expansion into Preventive CardiologyUltrasound-based Software Helps Determine Cardiovascular RiskBOTHELL, WA, May 27, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, announced today that it has acquired privately held SonoMetric Health, Inc., a developer of proprietary software to assess and manage cardiovascular disease in conjunction with an ultrasound examination. Terms of the agreement with SonoMetric were not disclosed. The transaction is not expected to have a material impact on Sonosite's 2004 financial results. "This acquisition is the initial step in implementing our preventive cardiology strategy and expanding our focus on providing ultrasound tools for detecting and managing cardiovascular disease," said Kevin M. Goodwin, Sonosite President and CEO. "We believe that the software developed by SonoMetric, when paired with our current and future hand-carried technologies, offers a major opportunity to impact the early stages of cardiovascular disease when treatment is most effective and that this technology can be cost-effectively leveraged throughout the care path, including the patient's physical exam."

Live Presentation Available Via Audio-WebcastBOTHELL, WA, May 5, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced that Kevin M. Goodwin, president and CEO of Sonosite, will present at the Deutsche Bank Health Care Conference at 3:00 pm. (EDT) on Wednesday May 5, 2004 at the Renaissance Harborplace Hotel in Baltimore.About SonositeSonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound, with an installed base of more than 20,000 systems. The Company, headquartered near Seattle, Washington is represented by eight subsidiaries and a global distribution netwok in over 75 countries. Sonosite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The Company employs approximately 450 people worldwide.

New Features include Advanced Analysis and Calculations Package for Obstetricians, Gynecologists and Fertility SpecialistsUpgrade Available to TITAN Installed Base via CompactFlash CardCustomer Shipments to Begin this WeekPHILADELPHIA, May 3, 2004 - (Nasdaq: SONO), the worldwide leader in high-performance, hand-carried ultrasound, today announced at the 52nd Annual Meeting of the American College of Obstetricians and Gynecologists (ACOG) that it is adding expanded OB/Gyn calculations and measurement capabilities on TITAN, the company's newest generation, hand-carried system. Sonosite will begin shipments of the new capabilities this week and customers can easily upgrade their existing TITAN systems via a CompactFlash card. Sonosite will be introducing these new capabilities in Booth #865 during the ACOG meeting in Philadelphia from May 3 - 5, 2004. "OB/Gyn physicians have been anchor market adopters of Sonosite's technology since we introduced the first hand-carried ultrasound systems," said Kevin M. Goodwin, Sonosite president and CEO. "Their input has been critical as we developed TITAN and this latest upgrade to address their needs for a high-performance system that was robust enough to travel with them from patient to patient."

Acquires Leading Ultrasound Educator to Spearhead EffortAppoints Directors for Global Education and Emerging MarketsBOTHELL, WA - April 30, 2004 - (Nasdaq: SONO), the leader in high-performance, hand-carried ultrasound, today announced plans to expand its global education programs in new clinical markets. To help facilitate its plans, the company also announced today it has acquired the assets of Chicago-based Windy City Ultrasound, Inc., a leading provider of ultrasound education for health care professionals. Terms of the agreement with Windy City were not disclosed."The most rapidly growing markets for hand carried ultrasound are for new and emerging applications," said Kevin M. Goodwin, Sonosite president and CEO. "As the innovators and leaders of the hand-carried ultrasound market, we believe Sonosite has a unique opportunity to accelerate the adoption of this technology into both new and traditional ultrasound markets by making available the best clinical education and information about these evolving applications and standards of care to our customers. Our new initiative is focused on achieving this goal."

Company Begins to Regain Momentum in JapanWorldwide Sales and Marketing Executive Team StrengthenedBOTHELL, WA, April 29, 2004 - Sonosite, Inc. (Nasdaq: SONO), the leader in high performance, hand-carried ultrasound, today announced increased revenue and a reduced loss for the first quarter ended March 31, 2004 as compared with the first quarter of 2003. Worldwide revenue in the first quarter of 2004 grew 37% to $23.5 million compared to $17.2 million in the first quarter of 2003. The Company reported a net loss of $1.4 million or $0.10 per share for the quarter compared to a net loss of $2.6 million or $0.18 per share in the first quarter of 2003. As of March 31, 2004, cash, cash equivalents and investments grew to $64.1 million. The Company generated cash from operations of $2.8 million.